Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion type Assertion NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_head.
- NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion wasGeneratedBy ECO_0000203 NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_provenance.
- NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion wasDerivedFrom befree-20140225 NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_provenance.
- NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion SIO_000772 11431104 NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_provenance.
- NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion evidence source_evidence_literature NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_provenance.
- NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_assertion description "[It was found that 78.9% of dMTase-positive cancers had both c-erbB-2 promoter and survivin gene exon 1 unmethylated, whereas 40% of dMTase-negative cancers had both sites methylated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549496.RArebefSo8Kw5TP7mf_AeU-FYM0sdXwrH3MrD461-vjeI130_provenance.